Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 145.80
+0.90 (0.62%)
At close: Oct 15, 2026
DSE:BXPHARMA Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, DSE:BXPHARMA stock has a consensus rating of "Strong Buy" and an average price target of ৳198.55. The average 1-year stock price forecast is 36.18% higher than the current stock price, while the lowest is ৳138.50 (-5.01%) and the highest is ৳258.60 (+77.37%).
Price Target: ৳198.55 (+36.18%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DSE:BXPHARMA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Oct '25 | Feb '26 | Mar '26 | Jul '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 1 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 1 | 3 | 2 |
Financial Forecast
Revenue This Year
54.78B
from 49.12B
Increased by 11.53%
Revenue Next Year
61.27B
from 54.78B
Increased by 11.84%
EPS This Year
19.42
from 15.56
Increased by 24.81%
EPS Next Year
22.23
from 19.42
Increased by 14.47%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BDT.